Home Cart 0 Sign in  
X

[ CAS No. 98948-95-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 98948-95-9
Chemical Structure| 98948-95-9
Chemical Structure| 98948-95-9
Structure of 98948-95-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 98948-95-9 ]

Related Doc. of [ 98948-95-9 ]

Alternatived Products of [ 98948-95-9 ]

Product Details of [ 98948-95-9 ]

CAS No. :98948-95-9 MDL No. :MFCD01569278
Formula : C10H6BrNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :GIUZUAUCCUFVKW-UHFFFAOYSA-N
M.W : 268.06 Pubchem ID :693203
Synonyms :

Calculated chemistry of [ 98948-95-9 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 58.43
TPSA : 70.42 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 2.6
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 0.35
Log Po/w (SILICOS-IT) : 1.98
Consensus Log Po/w : 1.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.57
Solubility : 0.0726 mg/ml ; 0.000271 mol/l
Class : Soluble
Log S (Ali) : -3.73
Solubility : 0.0501 mg/ml ; 0.000187 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.35
Solubility : 0.119 mg/ml ; 0.000444 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.46

Safety of [ 98948-95-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 98948-95-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 98948-95-9 ]
  • Downstream synthetic route of [ 98948-95-9 ]

[ 98948-95-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 98948-95-9 ]
  • [ 145369-94-4 ]
YieldReaction ConditionsOperation in experiment
95% for 9 h; Heating / reflux The solid 6-bromo-4-hydroxy-quinoline-3-carboxylic acid (102.59 g, 337.7 mmol) was added to hot diphenyl ether (508 g) and then the mixture was heated to reflux for 9 h to afford a light brown suspension.
After cooling to room temperature, the mixture was diluted with methanol (20 mL) and diethyl ether (300 mL).
Then, the solids were collected by filtration and washed with diethyl ether.
After drying in air, 72.43 g (95percent yield) of 6-bromo-quinolin-4-ol was isolated as a white solid: EI-HRMS m/e calcd for C9H6BrNO (M+) 222.9633, found 222.9630.
90% for 0.5 h; Reflux . Deprotection and removal of the carboxylic acid
90% for 0.5 h; Reflux 10558] The bicyclic compound 3-2 is prepared from bromoaniline 3-1 using diethyl 2-(ethoxymethylene)malonate or a similar reagent. Deprotection and removal of the carboxylic acid, followed by halogenation using a reagent such as phosphorus oxychloride yields compound 3-5. Derivatization with pyridine boronate in Suzuki coupling conditions yields 3-6, which is reacted in a second Suzuki reaction with a benzothiazolyl boronate to yield compound 3-7. Subsequent heating in hydrochloric acid in a solvent such as methanol results in removal of an acetyl group.
77% at 260℃; for 2 h; 4.1.7
6-Bromoquinolin-4-ol (10)
6-Bromo-4-hydroxyquinoline-3-carboxylic acid (9) (5.0 g, 18.73 mmol) was added to a 100 mL round-bottomed flask in Ph2O (30 mL) and then stirred at 260 °C for 2 h.
After cooling to 60 °C, 30 mL petroleum ether was added and the suspended solid was filtered, washed with petroleum ether, EtOAc and dried under reduced pressure to give the title compound (3.21 g, 14.39 mmol, 77percent yield) as a brown solid. ESI-MS: m/z = 224 [M+H]+.

Reference: [1] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[2] Patent: US2006/63805, 2006, A1, . Location in patent: Page/Page column 9
[3] Patent: WO2012/116237, 2012, A2, . Location in patent: Page/Page column 120
[4] Patent: US2015/320727, 2015, A1, . Location in patent: Paragraph 0557; 0558
[5] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 36 - 50
[6] Journal of the Chemical Society, 1950, p. 384,389
[7] Tetrahedron Letters, 2008, vol. 49, # 19, p. 3137 - 3141
[8] Patent: WO2014/151147, 2014, A1, . Location in patent: Paragraph 00641
[9] Patent: US2015/30588, 2015, A1, . Location in patent: Page/Page column 77
[10] Patent: US9295673, 2016, B2, . Location in patent: Page/Page column 365; 366
[11] Patent: WO2006/132739, 2006, A2, . Location in patent: Page/Page column 44-45
  • 2
  • [ 98948-95-9 ]
  • [ 65340-70-7 ]
Reference: [1] Journal of the Chemical Society, 1950, p. 384,389
[2] Patent: WO2012/116237, 2012, A2,
[3] Patent: WO2014/151147, 2014, A1,
[4] Patent: US2015/30588, 2015, A1,
[5] Patent: US2015/320727, 2015, A1,
[6] Patent: US9295673, 2016, B2,
[7] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[8] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 36 - 50
[9] Patent: CN106432073, 2017, A,
[10] Patent: WO2006/132739, 2006, A2,
  • 3
  • [ 98948-95-9 ]
  • [ 65340-70-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 14, p. 5522 - 5537
  • 4
  • [ 122794-99-4 ]
  • [ 98948-95-9 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: for 5 h; Heating / reflux
Stage #2: With hydrogenchloride In water
A suspension of 6-bromo-4-hydroxy-quinoline-3-carboxylic acid ethyl ester (102.59 g, 337.7 mmol) in 10percent potassium hydroxide in water (689 mL) was heated to reflux for 5 h to afford a light brown solution.
After cooling to room temperature, the undissolved solid particles were removed by filtration and the filtrate was extracted with dichloromethane to remove any neutral impurities.
The aqueous layer was neutralized with 3.0N hydrochloric acid to afford a white precipitate.
Then, the solids were collected by filtration and washed with water.
After drying in air, 91 g (98percent yield) of 6-bromo-4-hydroxy-quinoline-3-carboxylic acid was isolated as a white solid: EI-HRMS m/e calcd for C10H6BrNO3 (M+) 266.9531, found 266.9521.
96% for 1 h; Reflux Ethyl 6-bromo-4-hydroxy-3-quinolinecarboxylate (3.0 g, 10 mmol) was added to NaOH 10percent (40 mL)Should be heated to reflux for 1 hour. The reaction solution was cooled to ° C and adjusted to pH 1 with hydrochloric acid (10 N). Filtration, filter residue washed with water, dried 2.6g(96percent) of a white solid.
94% at 100℃; for 1 h; 4.1.6
6-Bromo-4-hydroxyquinoline-3-carboxylic acid (9)
Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate (8) (6.0 g, 20.34 mmol) and 2.5 N NaOH (50 mL) were charged in a 100 mL round-bottomed flask.
The mixture was stirred at reflux for 1 h.
After cooling to room temperature, the pH of the mixture was adjusted to 5 using 2 N HCl and the resulting solid was filtered and washed with water.
The filter cake was then dried under reduced pressure to afford the title compound (5.15 g, 19.22 mmol, 94percent yield) as a white solid. 1H NMR (500 MHz, DMSO-d6) δ 12.51 (s, 1H), 8.63 (s, 1H, Ar-), 8.23 (d, J = 2.5 Hz, 1H, Ar-H), 7.87 (dd, J = 8.5, 2.5 Hz, 1H, Ar-H), 7.61 (d, J = 8.5 Hz, 1H, Ar-H). ESI-MS: m/z = 268 [M+H]+.
80% With sodium hydroxide In water for 1.5 h; Reflux 10558] The bicyclic compound 3-2 is prepared from bromoaniline 3-1 using diethyl 2-(ethoxymethylene)malonate or a similar reagent. Deprotection and removal of the carboxylic acid, followed by halogenation using a reagent such as phosphorus oxychloride yields compound 3-5. Derivatization with pyridine boronate in Suzuki coupling conditions yields 3-6, which is reacted in a second Suzuki reaction with a benzothiazolyl boronate to yield compound 3-7. Subsequent heating in hydrochloric acid in a solvent such as methanol results in removal of an acetyl group.

Reference: [1] Patent: US2006/63805, 2006, A1, . Location in patent: Page/Page column 9
[2] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[3] Patent: CN106432073, 2017, A, . Location in patent: Paragraph 0061; 0062; 0067; 0068
[4] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 36 - 50
[5] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1995, vol. 31, # 2, p. 167 - 175[6] Khimiya Geterotsiklicheskikh Soedinenii, 1995, # 2, p. 195 - 203
[7] Patent: WO2012/116237, 2012, A2, . Location in patent: Page/Page column 120
[8] Patent: US2015/320727, 2015, A1, . Location in patent: Paragraph 0557; 0558
[9] Journal of the Chemical Society, 1950, p. 384,389
[10] Tetrahedron Letters, 2008, vol. 49, # 19, p. 3137 - 3141
[11] Patent: WO2014/151147, 2014, A1, . Location in patent: Paragraph 00641
[12] Patent: US2015/30588, 2015, A1, . Location in patent: Page/Page column 77
[13] Patent: US9295673, 2016, B2, . Location in patent: Page/Page column 365
[14] Patent: WO2006/132739, 2006, A2, . Location in patent: Page/Page column 44-45
  • 5
  • [ 106-40-1 ]
  • [ 98948-95-9 ]
Reference: [1] Journal of the Chemical Society, 1950, p. 384,389
[2] Patent: WO2012/116237, 2012, A2,
[3] Patent: WO2014/151147, 2014, A1,
[4] Patent: US2015/30588, 2015, A1,
[5] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[6] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 36 - 50
[7] Patent: US2015/320727, 2015, A1,
[8] Patent: US9295673, 2016, B2,
[9] Patent: CN106432073, 2017, A,
[10] Patent: WO2006/132739, 2006, A2,
  • 6
  • [ 101937-44-4 ]
  • [ 98948-95-9 ]
Reference: [1] Journal of the Chemical Society, 1950, p. 384,389
[2] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[3] Patent: CN106432073, 2017, A,
  • 7
  • [ 98948-95-9 ]
  • [ 916812-31-2 ]
Reference: [1] Patent: WO2006/132739, 2006, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 98948-95-9 ]

Bromides

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 798545-30-9

[ 798545-30-9 ]

6-Bromoquinoline-3-carboxylic acid

Similarity: 0.88

Chemical Structure| 1220418-77-8

[ 1220418-77-8 ]

Methyl 6-bromoquinoline-3-carboxylate

Similarity: 0.85

Chemical Structure| 1001756-23-5

[ 1001756-23-5 ]

Methyl 7-bromoquinoline-3-carboxylate

Similarity: 0.85

Chemical Structure| 122794-99-4

[ 122794-99-4 ]

Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.84

Alcohols

Chemical Structure| 34785-11-0

[ 34785-11-0 ]

4-Hydroxyquinoline-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 28027-16-9

[ 28027-16-9 ]

4-Hydroxy-6-methoxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 122794-99-4

[ 122794-99-4 ]

Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.84

Chemical Structure| 1137826-05-1

[ 1137826-05-1 ]

6-Hydroxyquinoline-3-carboxylic acid

Similarity: 0.81

Carboxylic Acids

Chemical Structure| 34785-11-0

[ 34785-11-0 ]

4-Hydroxyquinoline-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 798545-30-9

[ 798545-30-9 ]

6-Bromoquinoline-3-carboxylic acid

Similarity: 0.88

Chemical Structure| 28027-17-0

[ 28027-17-0 ]

4-Hydroxy-7-methoxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 28027-16-9

[ 28027-16-9 ]

4-Hydroxy-6-methoxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 347146-16-1

[ 347146-16-1 ]

8-Bromoquinoline-3-carboxylic acid

Similarity: 0.83

Related Parent Nucleus of
[ 98948-95-9 ]

Quinolines

Chemical Structure| 34785-11-0

[ 34785-11-0 ]

4-Hydroxyquinoline-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 798545-30-9

[ 798545-30-9 ]

6-Bromoquinoline-3-carboxylic acid

Similarity: 0.88

Chemical Structure| 1220418-77-8

[ 1220418-77-8 ]

Methyl 6-bromoquinoline-3-carboxylate

Similarity: 0.85

Chemical Structure| 1001756-23-5

[ 1001756-23-5 ]

Methyl 7-bromoquinoline-3-carboxylate

Similarity: 0.85